Naloxone & Alternative Opioid Antagonists - Buffer Stock Storage & Management
key details
| Value | £500,000 |
|---|---|
| Status | planning |
| Category (CPV) | 33600000 +2 more |
| SME suitable | Yes |
| OCID | ocds-b5fd17-5eb47ddb-ee59-46f1-9bd0-8fe674517b61 |
description
DHSC is conducting a market engagement exercise to understand more about the companies and services in the UK that can, or that are seeking to produce, distribute, supply and store different formulations of naloxone and of other drugs that can reverse the effect of an opioid overdose or of drugs taken with opioids.
The outcome of the market engagement will inform decisions around potential future procurement and storage of buffer stock as well as providing information on how the market could meet a potential increase in demand across the UK.
For avoidance of doubt
this is not a call for competition,
the purpose is to seek feedback from the market that may inform the final specification and/or procurement approach to the goods and services.
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 3 Apr 2024 | Planning (planning) | · | b702d08b-f9d2-4f4b-8324-726e540e6177-737409 |
| 4 Apr 2024 | Planning (planning) | · | 3ac42123-9732-4617-9d5f-75f2f65e03aa-737903 |
more from Department of Health and Social Care (DHSC)
- Hugh's Report-MH Impact of Life-threatening Child Illness on families 2026 · £216,540 · 26 Jun 2026
- D&B + API Interface · £542,011 · 25 Jun 2026
- NCMP IT System - Discovery Phase · £183,768 · 19 May 2026
- DHSC: CL Temporary Executive Support to the Permanent Secretary - JW · £17,702 · 19 May 2026
- DHSC: GO: 26/27 - WIST: DAC hosting on CSP · £168,000 · 2 Apr 2026
- RM1043.8-1-DEPARTMENT OF HEALTH AND SOCIAL CARE - Find Public Health Data · £1,251,360 · 2 Apr 2026
- DHSC:NHST: National GP Engagement on Health Data · £267,000 · 31 Mar 2026
- DHSC: CL FGO Contingent Labour SD Extension · £133,710 · 31 Mar 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.